Methotrexate induces cell swelling and necrosis in renal tubular cells

Pediatr Blood Cancer. 2006 May 1;46(5):624-9. doi: 10.1002/pbc.20471.

Abstract

Background: The present study was carried out to investigate if methotrexate (MTX) has a direct lethal effect in renal tubular cells, and if so, to further clarify the mechanisms of cell death.

Materials and methods: Renal tubular cells (LLC-PK(1) cells) were incubated with MTX (0.01 microM, 0.1 microM, and 1 microM), either alone or in combination with 0.1 microM amiloride (Na(+)/H(+) antiporter inhibitor) or 1 microM carbachol (M-cholinergic agonist). Cell viability was then determined by means of trypan blue (TB) exclusion tests and MTT assays.

Results: After 4 hr incubation with 0.1 microM MTX the number of viable cells was decreased by 18% in comparison with control cells, and the proportion of dead cells was increased by 38%. Cell death induced by MTX was time-dependent and did not show apoptotic features. On the contrary, cell swelling was discovered. This cell death was prevented by co-incubating the cells with amiloride or carbachol.

Conclusions: MTX induces cell swelling and cell death in renal tubular LLC-PK(1) cells. The tubular cell death induced by MTX is time-dependent. Cell death can be prevented by co-incubating with amiloride, thus indicating that the Na(+)/H(+) antiporter and possibly other volume regulatory factors in renal tubular cells are involved in MTX-induced renal failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiloride / pharmacology
  • Animals
  • Antimetabolites, Antineoplastic / pharmacology*
  • Cell Size / drug effects*
  • Cell Survival / drug effects*
  • Kidney Tubules, Proximal / drug effects*
  • Kidney Tubules, Proximal / pathology
  • LLC-PK1 Cells / cytology
  • LLC-PK1 Cells / drug effects
  • Methotrexate / pharmacology*
  • Necrosis
  • Sodium Channel Blockers / pharmacology
  • Swine

Substances

  • Antimetabolites, Antineoplastic
  • Sodium Channel Blockers
  • Amiloride
  • Methotrexate